Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
Eugen Ruckhäberle(Goethe University Frankfurt), Manfred Kaufmann(Goethe University Frankfurt), Achim Rody(Goethe University Frankfurt), Knut Engels(Goethe University Frankfurt), R. Gaetje(Goethe University Frankfurt), Gerd Geißlinger(Goethe University Frankfurt), Susanne Schiffmann(Fraunhofer Institute for Translational Medicine and Pharmacology), Gϋnter von Minckwitz(German Breast group), Thomas Karn(Goethe University Frankfurt), Sabine Grösch(Goethe University Frankfurt), Uwe Holtrich(Goethe University Frankfurt)
Cited by 297
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
|The Lancet|2007|1.5k
Cyclooxygenase‐independent actions of cyclooxygenase inhibitors
|The FASEB Journal|2001|739
GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence
|Nature Medicine|2006|546